Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIFUND-MS: Rituximab versus Dimethyl Fumarate in Newly Diagnosed Multiple Sclerosis
2015-004116-38Phase 3Completed
- Sponsor
- Karolinska Institutet Danderyds Sjukhus
- Start
- Oct 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in multiple sclerosis (MS) comparing Rituximab with Dimethyl fumarate (2 arms). Started Oct 2015; status: completed.
02
Drugs
rituximabdimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2015-004116-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004116-38.